Heart ultrasound may guide better septic shock treatment

NCT ID NCT07438301

Not yet recruiting Knowledge-focused Sponsor: Mahidol University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will use echocardiograms (heart ultrasounds) to see how the heart responds to two common treatments for septic shock: intravenous fluids and vasopressors (medicines that raise blood pressure). Researchers will measure changes in heart function before and 15 minutes after treatment in 180 adults with septic shock. The goal is to understand which approach improves blood flow better, which could help doctors make more informed resuscitation decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors choose the best resuscitation method for septic shock patients based on heart function changes.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not apply to all patients, and the small size (180 participants) limits generalizability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sepsis toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPTIC SHOCK

Contacts and locations

Locations

Siriraj Hospital

Bangkok, 10700, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.